文献速递泌尿生殖腹部MR

基于PI-RR系统评估前列腺癌局部复发的MRI诊断准确性、不同经验阅片者间观察者可靠性及与PSA值的相关性

An MRI assessment of prostate cancer local recurrence using the PI-RR system: diagnostic accuracy, inter-observer reliability among readers with variable experience, and correlation with PSA values.
PubMed 文献 · Eur Radiol · 2023-08-30

本回顾性研究纳入120例根治性前列腺切除或放疗后怀疑局部复发并接受盆腔MRI的患者,由5名不同经验阅片者独立评估PI-RR评分。以PI-RR≥3分为复发阳性,敏感度79-86%、特异度64-86%、准确率79-87%,观察者间可靠性良好至优秀(κ 0.52-0.77,ICC 0.8),PSA速度、基线PSA和触发PSA可预测影像学局部复发。

要点

  • PI-RR评分≥3分判为复发阳性时,敏感度79-86%、特异度64-86%、准确率79-87%。
  • 5名不同经验阅片者间观察者可靠性良好至优秀,κ范围0.52-0.77,ICC为0.8。
  • PSA速度、基线PSA和触发PSA可预测影像学局部复发。

核心结论

  • PI-RR系统是MRI评估前列腺癌局部复发的有效工具,有助于提高放射科医师间的一致性。

研究设计与样本

  • 回顾性纳入2017年10月至2020年2月因怀疑根治性前列腺切除或放疗后局部复发而接受盆腔MRI的患者120例,由2名高年资和3名低年资放射科医师独立评估PI-RR评分,参考标准为生化、影像或组织病理随访数据。

诊断标准与关键数值

  • 以PI-RR评分≥3分作为复发阳性,各阅片者间敏感度79-86%、特异度64-86%、阳性预测值95-98%、阴性预测值33-46%、准确率79-87%。

临床应用与阅片要点

  • 作者认为PI-RR评估评分可能促进前列腺癌局部复发评估的标准化和可推广性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The Prostate Imaging for Recurrence Reporting (PI-RR) system has been recently proposed to promote standardisation in the MR assessment of prostate cancer (PCa) local recurrence after radical prostatectomy (RP) and radiation therapy (RT). This study aims to evaluate PI-RR's diagnostic accuracy, assess the inter-observer reliability among readers with variable experience, and correlate imaging results with anatomopathological and laboratory parameters.

METHODS: Patients who underwent a pelvic MRI for suspicion of PCa local recurrence after RP or RT were retrospectively enrolled (October 2017-February 2020). PI-RR scores were independently assessed for each patient by five readers with variable experience in prostate MRI (two senior and three junior radiologists). Biochemical data and histopathological features were collected. The reference standard was determined through biochemical, imaging, or histopathological follow-up data. Reader's diagnostic performance was assessed using contingency tables. Cohen's kappa coefficient (κ) and intraclass correlation coefficient (ICC) were calculated to measure inter-observer reliability.

RESULTS: The final cohort included 120 patients (median age, 72 years [IQR, 62-82]). Recurrence was confirmed in 106 (88.3%) patients. Considering a PI-RR score ≥ 3 as positive for recurrence, minimum and maximum diagnostic values among the readers were as follows: sensitivity 79-86%; specificity 64-86%; positive predictive value 95-98%; negative predictive value 33-46%; accuracy 79-87%. Regardless of reader's level of experience, the inter-observer reliability resulted good or excellent (κ ranges across all readers: 0.52-0.77), and ICC was 0.8. Prostate-specific antigen (PSA) velocity, baseline-PSA, and trigger-PSA resulted predictive of local recurrence at imaging.

CONCLUSIONS: The PI-RR system is an effective tool for MRI evaluation of PCa local recurrence and facilitates uniformity among radiologists.

CLINICAL RELEVANCE STATEMENT: This study confirmed the PI-RR system's good diagnostic accuracy for the MRI evaluation of PCa local recurrences. It showed high reproducibility among readers with variable experience levels, validating it as a promising standardisation tool for assessing patients with biochemical recurrence.

KEY POINTS: • In this retrospective study, the PI-RR system revealed promising diagnostic performances among five readers with different experience (sensitivity 79-86%; specificity 64-86%; accuracy 79-87%). • The inter-observer reliability among the five readers resulted good or excellent (κ ranges: 0.52-0.77) with an intraclass correlation coefficient of 0.8. • The PI-RR assessment score may facilitate standardisation and generalizability in the evaluation of prostate cancer local recurrence among radiologists.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Franco PN, Frade-Santos S, García-Baizán A, et al. An MRI assessment of prostate cancer local recurrence using the PI-RR system: diagnostic accuracy, inter-observer reliability among readers with variable experience, and correlation with PSA values. Eur Radiol. 2023. PMID: 37646815. doi:10.1007/s00330-023-09949-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。